IL-2 taken to HAART
- PMID: 11366116
Item in Clipboard
IL-2 taken to HAART
GMHC Treat Issues.
1999 Feb.
Abstract
AIDS: Some studies show that IL-2 combined with highly active antiretroviral therapy (HAART) may cleanse the body of HIV. This was covered in several reports during the 6th Retrovirus Conference. While the drug appears to increase CD4 levels, it has serious side effects and must be used with caution. Several studies and theories of IL-2 are discussed, but it is too early to judge the long-term effects of IL-2 on HIV replication. One doctor warns that patients should not use IL-2 unless they are part of a clinical trial or consulting an expert on the drug.
Similar articles
-
Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy.Nat Med. 1999 Jun;5(6):651-5. doi: 10.1038/9498. Nat Med. 1999. PMID: 10371503 Clinical Trial.
-
Increase of HIV-1 pro-viral DNA per million peripheral blood mononuclear cells in patients with advanced HIV disease (CD4<200 cells/mm3) receiving interleukin 2 combined with HAART versus HAART alone (ANRS-082 trial).Antivir Ther. 2003 Jun;8(3):233-7. Antivir Ther. 2003. PMID: 12924540 Clinical Trial.
-
Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Verh K Acad Geneeskd Belg. 2001. PMID: 11813503 Review.
-
HIV-1 and HAART: a time to cure, a time to kill.Nat Med. 1999 Jun;5(6):609-11. doi: 10.1038/9452. Nat Med. 1999. PMID: 10371490 No abstract available.
-
[The role of therapeutic use of interleukin-2 in HIV infection].Przegl Epidemiol. 2002;56(4):587-93. Przegl Epidemiol. 2002. PMID: 12666584 Review. Polish.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials